Device Trial Radar · NCT07129915
Nudge-Based Shared Decision Making and Self-Management in Type 2 Diabetes: A Randomized Trial
Last checked: Nov 20, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
280
Actual
Start
Nov 1, 2025
Primary completion
Oct 17, 2026
Study completion Oct 17, 2026
Sponsor
- Lead sponsor
- Yunxuan LiAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 19, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Health services research
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study aims to test whether a communication strategy called "linguistic nudging" can help doctors and patients with type 2 diabetes make better treatment decisions together, and whether this improves patients' ability to manage their condition. What will happen in the study? - 250 adults with type 2 diabetes from Xiang'an Hospital (Xiamen) will be randomly assigned to one of two groups: Intervention group:Doctors will receive special training in "linguistic nudging" techniques to encourage shared decision-making. Patients will use a mobile app to record medication preferences, and doctors will adjust advice based on these preferences. Control group:Patients will receive standard diabetes care without these additional strategies. \- All participants will be followed for 6 months. What is the study aiming to find out? The main goal is to see if patients in the intervention group: Better follow medication plans Improve blood sugar monitoring Have better blood sugar control Feel more satisfied with doctor-patient communication Why is this important? Good self-management is key to controlling diabetes, but many patients struggle with it. Effective communication during shared decision-making may empower patients to manage their condition day-to-day with greater confidence. Patient safety and rights: Participation is completely voluntary All personal information will be kept strictly confidential Medical support will be provided if any health problems occur during the study Participants may withdraw at any time This research has been approved by the Ethics Committee of Xiang'an Hospital (Approval date: October 2025).
Conditions
- Diabetes Mellitus, Type 2
- Physician-Patient Relations
- Self-management
Interventions
Linguistic Nudging TrainingBehavioral
Physicians receive 4-hour communication training to optimize shared decision-making using behavioral nudging techniques
Medication Preference AppDevice
Patients use WeChat-based mini-program to record daily medication preferences and concerns
Standard Diabetes CareOther
Routine follow-up visits, HbA1c monitoring, and basic health education per hospital protocol
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Glycated Hemoglobin (HbA1c) LevelTime frame: Baseline and Month 6
2 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Xiang'an Hospital Affiliated to Xiamen University
Xiamen, Fujian, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.